Drug Type Autologous CAR-T |
Synonyms Anti-CDH17 CAR-T Cell(Guangzhou Bio-gene Technology), BG 2204, BG2204 |
Target |
Action antagonists |
Mechanism CDH17 antagonists(Cadherin-17 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CDH17-positive Solid Tumor | Phase 1 | China | 01 Mar 2025 |





